查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946609

2026年全球下一代腫瘤治療設備和解決方案市場報告

Next-Generation Oncology Devices And Solutions Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，新一代腫瘤治療設備和解決方案市場規模迅速擴張，預計將從2025年的164.1億美元成長到2026年的194.6億美元，複合年成長率達18.6%。過去幾年的成長可歸因於全球癌症發生率的上升、分子診斷能力的增強、先進腫瘤檢測工具的普及、醫院癌症治療計畫的增加以及標靶治療的日益普及。

預計未來幾年，下一代腫瘤設備和解決方案市場將快速成長，到2030年市場規模將達到381.9億美元，複合年成長率（CAGR）為18.4%。預測期內的成長要素包括：對個人化癌症治療的需求不斷成長、基因組診斷投資增加、早期篩檢計畫擴展、人工智慧在腫瘤工作流程中的應用日益廣泛，以及基於生物標記的癌症管理技術不斷進步。主要趨勢包括：精準腫瘤平台的日益普及、基於次世代定序（NGS）的癌症診斷技術的廣泛應用、數位病理解決方案的日益整合、個人化癌症治療方法的擴展，以及對早期檢測技術的日益重視。

癌症發生率的不斷上升預計將推動下一代腫瘤治療設備和解決方案市場的擴張。癌症是一種以異常細胞不受控制地生長為特徵的疾病，這些異常細胞會擴散到身體其他部位並破壞正常功能。癌症發生率的上升主要是由於人口老化，罹患癌症風險老齡化增加而增加。下一代腫瘤治療設備和解決方案透過實現早期檢測、高精度診斷和個人化治療，有助於應對這一日益成長的趨勢。例如，根據美國非營利組織美國癌症協會於2024年1月發布的估計數據，美國癌症相關死亡人數將超過61.1萬人，相當於每天超過1,600人死於癌症。因此，癌症發生率的不斷上升是推動下一代腫瘤治療設備和解決方案市場成長的主要因素。

下一代腫瘤設備和解決方案市場的主要企業正致力於技術創新，例如次世代定序(NGS)靶向序列捕獲解決方案，以提高罕見基因突變檢測的準確性、增強定序精度並加速癌症診斷和治療決策。 NGS靶向序列捕獲方案能夠選擇性地捕獲和富集特定的 DNA 或 RNA 區域進行定序，從而實現對與癌症和其他疾病相關的基因突變進行更精確、更高效的分析。例如，2025 年 4 月，美國生物技術公司 Integrated DNA Technologies (IDT) 發布了 xGen Hybridization and Wash v3 Kit，這是一種先進的雜合反應捕獲解決方案，可透過簡化 NGS 工作流程來加速癌症研究。該試劑盒將雜合反應時間縮短至僅一小時，使研究人員能夠在一天內完成從樣本製備到定序的整個過程。此解決方案無需加熱緩衝液，並將人工操作時間減少了 20%，非常適合自動化操作，是高通量應用的理想選擇。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球下一代腫瘤治療設備及解決方案市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 永續性、氣候技術和循環經濟
  • 主要趨勢
    • 精準腫瘤學平台的廣泛應用
    • 擴大基於次世代定序（NGS）的癌症診斷的應用
    • 數位病理解決方案的整合程度日益提高
    • 拓展個人化癌症治療方法
    • 人們越來越關注早期檢測技術

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 專業腫瘤中心
  • 學術研究機構
  • 癌症研究所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球下一代腫瘤治療設備和解決方案市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球下一代腫瘤治療設備及解決方案市場規模、對比及成長率分析
  • 全球下一代腫瘤治療設備和解決方案市場表現：規模和成長，2020-2025年
  • 全球下一代腫瘤治療設備及解決方案市場預測：規模及成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按癌症類型
  • 乳癌、子宮頸癌、結腸癌、肺癌
  • 透過技術
  • 次世代定序（NGS）、聚合酵素鏈鎖反應（PCR）、DNA微陣列、多重分析及其他技術
  • 透過使用
  • 篩檢和早期檢測、預後診斷和後續觀察、治療選擇、復發監測及其他用途
  • 按最終用途
  • 醫院/診所、診斷檢查室、學術研究機構和其他最終用途
  • 按類型細分：乳癌
  • 侵襲性乳管癌、侵襲性小葉癌、三陰性乳癌、HER2陽性乳癌
  • 按類型細分：子宮頸癌
  • 鱗狀細胞癌、腺癌、腺鱗癌
  • 按類型細分：大腸直腸癌
  • 結腸癌、直腸癌、轉移性大腸癌
  • 按類型細分：肺癌
  • 非小細胞肺癌（NSCLC）、小細胞肺癌（SCLC）、肺腺癌、鱗狀細胞肺癌

第10章 區域與國家分析

  • 全球下一代腫瘤治療設備及解決方案市場：區域分析、預測及趨勢（2020-2025年、2025-2030年預測、2035年預測）
  • 全球下一代腫瘤治療設備及解決方案市場：國家/地區、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 下一代腫瘤治療設備和解決方案市場：競爭格局和市場佔有率（2024 年）
  • 下一代腫瘤治療設備及解決方案市場：公司估值矩陣
  • 下一代腫瘤治療設備及解決方案市場：公司概況
    • Johnson & Johnson Services Inc.
    • Siemens AG
    • Merck & Co. Inc.
    • Thermo Fisher Scientific Inc.
    • Novartis AG

第37章：其他領先和創新企業

  • Koninklijke Philips NV, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN NV, Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年下一代腫瘤設備和解決方案市場：提供新機會的國家
  • 2030年下一代腫瘤設備和解決方案市場：提供新機會的細分市場
  • 2030年下一代腫瘤設備和解決方案市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MNGOD01_G26Q1

Next-generation oncology devices and solutions encompass advanced technologies and tools developed to detect, diagnose, monitor, and treat various forms of cancer with enhanced precision and speed. Their goal is to facilitate personalized cancer care by utilizing innovations such as next-generation sequencing, digital pathology, and targeted therapies to improve patient outcomes.

The primary cancer types addressed by next-generation oncology devices and solutions include breast cancer, cervical cancer, colorectal cancer, and lung cancer. Breast cancer is a condition where cells in the breast grow uncontrollably, often forming a tumor that can be felt as a lump or identified through imaging. These solutions employ technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), DNA microarrays, multiplexing, and other advanced techniques, which are applied in areas such as screening and early detection, prognostics and monitoring, therapy selection, and recurrence monitoring. The key end users include hospitals and clinics, diagnostic laboratories, academic and research institutions, and more.

Tariffs are influencing the next-generation oncology devices and solutions market by increasing costs of imported sequencing equipment, diagnostic reagents, imaging systems, electronic components, and precision manufacturing tools. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported advanced technologies, while Asia-Pacific faces pricing pressure on oncology device exports. These tariffs are raising testing and equipment costs and influencing procurement timelines. At the same time, they are encouraging domestic manufacturing, regional R&D investments, and local production of oncology diagnostic and therapeutic solutions.

The next-generation oncology devices and solutions market research report is one of a series of new reports from The Business Research Company that provides next-generation oncology devices and solutions market statistics, including next-generation oncology devices and solutions industry global market size, regional shares, competitors with a next-generation oncology devices and solutions market share, detailed next-generation oncology devices and solutions market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation oncology devices and solutions industry. This next-generation oncology devices and solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next-generation oncology devices and solutions market size has grown rapidly in recent years. It will grow from $16.41 billion in 2025 to $19.46 billion in 2026 at a compound annual growth rate (CAGR) of 18.6%. The growth in the historic period can be attributed to increasing global cancer incidence rates, expansion of molecular diagnostic capabilities, availability of advanced oncology testing tools, growth of hospital-based cancer care programs, rising adoption of targeted therapies.

The next-generation oncology devices and solutions market size is expected to see rapid growth in the next few years. It will grow to $38.19 billion in 2030 at a compound annual growth rate (CAGR) of 18.4%. The growth in the forecast period can be attributed to increasing demand for personalized cancer treatment, rising investments in genomic diagnostics, expansion of early screening programs, growing integration of ai in oncology workflows, advancements in biomarker-based cancer management. Major trends in the forecast period include increasing adoption of precision oncology platforms, rising use of ngs-based cancer diagnostics, growing integration of digital pathology solutions, expansion of personalized cancer treatment approaches, enhanced focus on early detection technologies.

The growing prevalence of cancer is expected to drive the expansion of the next-generation oncology devices and solutions market. Cancer is a disease characterized by uncontrolled growth of abnormal cells, which can spread to other areas of the body, disrupting normal functions. The increasing prevalence of cancer is mainly due to aging populations, as the risk of developing cancer rises with age. Next-generation oncology devices and solutions help address this rise by enabling earlier detection, more accurate diagnosis, and personalized treatment. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization, estimated that cancer would cause over 611,000 deaths in the United States, which equals more than 1,600 cancer-related deaths per day. As such, the growing prevalence of cancer is a key driver for the growth of the next-generation oncology devices and solutions market.

Leading companies in the next-generation oncology devices and solutions market are focusing on technological innovations, such as next-generation sequencing (NGS) target enrichment solutions, to improve the detection of rare genetic variants, enhance sequencing accuracy, and expedite cancer diagnosis and treatment decisions. NGS target enrichment solutions involve techniques that selectively capture and concentrate specific DNA or RNA regions for sequencing, allowing more precise and efficient analysis of genetic variants associated with cancer and other diseases. For instance, in April 2025, Integrated DNA Technologies (IDT), a US-based biotechnology company, launched the xGen Hybridization and Wash v3 Kit, an advanced hybridization capture solution designed to accelerate cancer research by streamlining NGS workflows. This kit reduces hybridization time to just one hour, enabling researchers to complete sample preparation and sequencing in a single workday. By eliminating the need for heated buffers and cutting hands-on time by 20%, the solution is highly automation-friendly and ideal for high-throughput applications.

In July 2024, Hologic, a US-based medical technology company, acquired Endomag for an undisclosed amount. This acquisition aims to enhance Hologic's breast cancer surgery portfolio by incorporating Endomag's innovative surgical guidance products, which improve the precision and effectiveness of cancer care. Endomag, a UK-based medical device manufacturer, specializes in surgical guidance products for breast cancer treatment.

Major companies operating in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., Lucida Medical Ltd.

North America was the largest region in the next-generation oncology devices and solutions market in 2025. The regions covered in the next-generation oncology devices and solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the next-generation oncology devices and solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The next-generation oncology devices and solutions market consists of revenues earned by entities by providing services such as cancer genomic profiling and sequencing, personalized treatment planning, remote patient monitoring and tele-oncology, and early cancer detection and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation oncology devices and solutions market also includes sales of liquid biopsy kits, companion diagnostic tests, digital pathology systems, cancer biomarker detection assays, and targeted therapy monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation Oncology Devices And Solutions Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses next-generation oncology devices and solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation oncology devices and solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation oncology devices and solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Cancer Type: Breast Cancer; Cervical Cancer; Colorectal Cancer; Lung Cancer
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); DNA Microarrays; Multiplexing; Other Technologies
  • 3) By Application: Screening And Early Detection; Prognostics And Monitoring; Therapy Selection; Recurrence Monitoring; Other Applications
  • 4) By End Use: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutions; Other End Uses
  • Subsegments:
  • 1) By Breast Cancer: Invasive Ductal Carcinoma; Invasive Lobular Carcinoma; Triple-Negative Breast Cancer; HER2-Positive Breast Cancer
  • 2) By Cervical Cancer: Squamous Cell Carcinoma; Adenocarcinoma; Adenosquamous Carcinoma
  • 3) By Colorectal Cancer: Colon Cancer; Rectal Cancer; Metastatic Colorectal Cancer
  • 4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC); Small Cell Lung Cancer (SCLC); Lung Adenocarcinoma; Squamous Cell Lung Carcinoma
  • Companies Mentioned: Johnson & Johnson Services Inc.; Siemens AG; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Novartis AG; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.; Agilent Technologies Inc.; Illumina Inc.; Sysmex Corporation; QIAGEN N.V.; Exact Sciences Corporation; Elekta AB; Myriad Genetics Inc.; Takara Bio USA Inc.; NeoGenomics Inc.; Guardant Health Inc.; Accuray Incorporated; SOPHiA GENETICS SA; Paige.AI Inc.; Deep Bio Inc.; Lucida Medical Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Next-Generation Oncology Devices And Solutions Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Next-Generation Oncology Devices And Solutions Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Next-Generation Oncology Devices And Solutions Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Next-Generation Oncology Devices And Solutions Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Precision Oncology Platforms
    • 4.2.2 Rising Use Of Ngs-Based Cancer Diagnostics
    • 4.2.3 Growing Integration Of Digital Pathology Solutions
    • 4.2.4 Expansion Of Personalized Cancer Treatment Approaches
    • 4.2.5 Enhanced Focus On Early Detection Technologies

5. Next-Generation Oncology Devices And Solutions Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Oncology Specialty Centers
  • 5.4 Academic And Research Institutions
  • 5.5 Cancer Research Organizations

6. Next-Generation Oncology Devices And Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Next-Generation Oncology Devices And Solutions Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Next-Generation Oncology Devices And Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Next-Generation Oncology Devices And Solutions Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Next-Generation Oncology Devices And Solutions Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Next-Generation Oncology Devices And Solutions Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Next-Generation Oncology Devices And Solutions Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Next-Generation Oncology Devices And Solutions Market Segmentation

  • 9.1. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer
  • 9.2. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), DNA Microarrays, Multiplexing, Other Technologies
  • 9.3. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Screening And Early Detection, Prognostics And Monitoring, Therapy Selection, Recurrence Monitoring, Other Applications
  • 9.4. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Uses
  • 9.5. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Breast Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer
  • 9.6. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Cervical Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
  • 9.7. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Colon Cancer, Rectal Cancer, Metastatic Colorectal Cancer
  • 9.8. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Lung Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma

10. Next-Generation Oncology Devices And Solutions Market Regional And Country Analysis

  • 10.1. Global Next-Generation Oncology Devices And Solutions Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Next-Generation Oncology Devices And Solutions Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Next-Generation Oncology Devices And Solutions Market

  • 11.1. Asia-Pacific Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Next-Generation Oncology Devices And Solutions Market

  • 12.1. China Next-Generation Oncology Devices And Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Next-Generation Oncology Devices And Solutions Market

  • 13.1. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Next-Generation Oncology Devices And Solutions Market

  • 14.1. Japan Next-Generation Oncology Devices And Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Next-Generation Oncology Devices And Solutions Market

  • 15.1. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Next-Generation Oncology Devices And Solutions Market

  • 16.1. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Next-Generation Oncology Devices And Solutions Market

  • 17.1. South Korea Next-Generation Oncology Devices And Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Next-Generation Oncology Devices And Solutions Market

  • 18.1. Taiwan Next-Generation Oncology Devices And Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Next-Generation Oncology Devices And Solutions Market

  • 19.1. South East Asia Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Next-Generation Oncology Devices And Solutions Market

  • 20.1. Western Europe Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Next-Generation Oncology Devices And Solutions Market

  • 21.1. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Next-Generation Oncology Devices And Solutions Market

  • 22.1. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Next-Generation Oncology Devices And Solutions Market

  • 23.1. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Next-Generation Oncology Devices And Solutions Market

  • 24.1. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Next-Generation Oncology Devices And Solutions Market

  • 25.1. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Next-Generation Oncology Devices And Solutions Market

  • 26.1. Eastern Europe Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Next-Generation Oncology Devices And Solutions Market

  • 27.1. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Next-Generation Oncology Devices And Solutions Market

  • 28.1. North America Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Next-Generation Oncology Devices And Solutions Market

  • 29.1. USA Next-Generation Oncology Devices And Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Next-Generation Oncology Devices And Solutions Market

  • 30.1. Canada Next-Generation Oncology Devices And Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Next-Generation Oncology Devices And Solutions Market

  • 31.1. South America Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Next-Generation Oncology Devices And Solutions Market

  • 32.1. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Next-Generation Oncology Devices And Solutions Market

  • 33.1. Middle East Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Next-Generation Oncology Devices And Solutions Market

  • 34.1. Africa Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Next-Generation Oncology Devices And Solutions Market Regulatory and Investment Landscape

36. Next-Generation Oncology Devices And Solutions Market Competitive Landscape And Company Profiles

  • 36.1. Next-Generation Oncology Devices And Solutions Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Next-Generation Oncology Devices And Solutions Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Next-Generation Oncology Devices And Solutions Market Company Profiles
    • 36.3.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Next-Generation Oncology Devices And Solutions Market Other Major And Innovative Companies

  • Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc.

38. Global Next-Generation Oncology Devices And Solutions Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Next-Generation Oncology Devices And Solutions Market

40. Next-Generation Oncology Devices And Solutions Market High Potential Countries, Segments and Strategies

  • 40.1 Next-Generation Oncology Devices And Solutions Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Next-Generation Oncology Devices And Solutions Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Next-Generation Oncology Devices And Solutions Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer